| Specifications | |
|---|---|
| Product type | mRNA |
| Modified bases | 5-Methyl-CTP |
| 5' Cap | Cap 0 |
| Species | Human |
| RefSeq | NM_001136.5 |
| Applications | Gene therapy research |
| Format | Powder |
| Quantity | 100 µg |
| Purification | Chromatography |
| Target Gene | |
|---|---|
| Gene ID | 177 |
| UniProt ID | Q15109 |
| Specifications | |
|---|---|
| Product type | mRNA |
| Modified bases | 5-Methyl-CTP |
| 5' Cap | Cap 0 |
| Species | Human |
| RefSeq | NM_001136.5 |
| Applications | Gene therapy research |
| Format | Powder |
| Quantity | 100 µg |
| Purification | Chromatography |
| Target Gene | |
|---|---|
| Gene ID | 177 |
| UniProt ID | Q15109 |
| Download |
|---|
| Download resources about mRNA therapeutics development to boost your research. |
| CUSTOMER REVIEWS and Q&As | |
|---|---|
|
There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human AGER, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) (GTTS-WK8696MR). Click the button above to contact us or submit your feedback about this product. |
|
| See other products | |||
|---|---|---|---|
| CAT | Product Name | Product Type | CDs |
| GTTS-WK4209MR | IVTScrip™ mRNA-Human CD200, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) | mRNA | CD200 |
| GTTS-WK3554MR | IVTScrip™ mRNA-Human CD3, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) | mRNA | CD3 |
| GTTS-WK16158MR | IVTScrip™ mRNA-Human ANXA2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) | mRNA | ANXA2 |
| GTTS-WK1317MR | IVTScrip™ mRNA-Human CD81, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) | mRNA | CD81 |
| GTTS-WK7087MR | IVTScrip™ mRNA-Human EBF2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) | mRNA | EBF2 |
| GTTS-WK4322MR | IVTScrip™ mRNA-Human CD85k, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) | mRNA | CD85k |
| GTTS-WK5367MR | IVTScrip™ mRNA-Human CD40, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) | mRNA | CD40 |
| GTTS-WK2455MR | IVTScrip™ mRNA-Human CD4, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) | mRNA | CD4 |